Abstract
Mesoporous silica materials are having an impact in traditional pharmaceutical applications and nanomedicine. As excipients, they are allowing the enhancement of poorly soluble drugs with significant improvements in solubility for a large variety of type II drug compounds. Synthetic and structural versatility allows to truly design both mesopore structure and mesopore size with great precision promising to allow for a library of standard materials that can deliver tailored pharmacokinetic release profiles. In this chapter, we highlight some of the important developments in the field of mesoporous materials focusing on early synthetic aspects as well as later functionalisation strategies. The characterisation methods that are employed commonly and may be used to facilitate production and quality assessment are also discussed. Finally, we update the reader with some brief examples of how these non-toxic and biocompatible vehicles are entering pharmaceutical applications.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adiseshaiah PP, Hall JB, McNeil SE (2010) Wiley Interdiscip Rev Nanomed Nanobiotechnol 2(1):99–112
Amidon GL, Lennernäs H, Shah VP, Crison JR (1995) A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 12:413–420
Atluri R, Hedin N, Garcia-Bennett AE (2008) Chem Mater 20(12):3857–3866
Atluri R, Hedin N, Garcia-Bennett AE (2009) J Am Chem Soc 131:3189
Atluri R, Iqbal M, Bacsik Z, Hedin N, Villaescusa LA, Garcia-Bennett AE (2013) Langmuir 29:12003–12012
Bacchi CJ, Nathan HC, Hutner SH (1980) Science 210(4467):332–334
Barret EP, Oyner LG, Halendar PH (1951) J Am Chem Soc 73:373
Beck JS, Princeton NY (1991) US Patent No. 5 057 296
Bellussi G, Perego C, Carati A, Peratello S, Massara EP, Perego G (1994) Stud Surf Sci Catal 84:85
Berggren A, Palmqvist AEC, Holmberg K (2005) Soft Matter 1:219–226
Brinker CJ, Scherer GW (1990) Sol-Gel science: the physics and chemistry of sol-gel processing. Academic Press, London
British Pharmacopoeia (2009) Volume I and II monographs: medicinal and pharmaceutical substances Colloidal Anhydrous Silica
Brohede U, Atluri R, Garcia-Bennett AE, Stromme M (2008) Curr Drug Deliv 5(3):177–185
Brunauer S (1944) Physical adsorption of gases and vapours. Oxford University Press, Oxford
Brunauer S, Emmett PH, Teller E (1938) J Am Chem Soc 60:309
Cedervall T et al (2007) Understanding the nanoparticle-protein corona usingmethods to quantify exchange rates and affinities of proteins fornanoparticles. Proc Natl Acad Sci U S A 104(7): 2050–2055
Che S, Garcia-Bennett AE, Yokoi T, Sakamoto K, Kunieda H, Terasaki O, Tatsumi T (2003) Nature Mater 2:801
Che S, Liu T, Ohsuna K, Sakamoto O, Terasaki T (2004) Tatsumi Nature 429:281
Chen CY, Burkett SL, Li HL, Davis ME (1993) Microporous Mater 2:27
Chiola V, Ritsko JE, Vanderpool CD (1971) US Patent No. 3556725
Chiou WL, Riegelman S (1971) Pharmaceutical applications of solid dispersion systems. J Pharm Sci 60:1281–1302
Chithrani BD, Ghazani AA, Chan WCW (2006) Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Letters 6(4):662–668
Cong YS, Wright WE, Shay JW (2002) Microbiol Mol Biol Rev 66(3):407–425
Cuatrecasas P (2006) J Clin Invest 116(11)
Davidson MH (2012) Am J Cardiol 110(9 Suppl):43B–49B
Davidsson A (2002) Current opinion in colloid and interface. Science 7:92–106
Davis JT, Spada GP (2007) Chem Soc Rev 36(2):296–313
Donaldson K et al (2011) Identifying the pulmonary hazard of high aspect ratio nanoparticles to enable their safety-by-design. Nanomedicine (Lond) 6(1):143–156
Doshi DA, Gibaud A, Goletto V, Lu M, Gerung H, Ocko B, Han SM, Brinker CJ (2003) J Am Chem Soc 125:11646
Downs TR et al (2012) Mutat Res 745(1–2):38–50
Fadeel B, Garcia-Bennett AE (2010) Adv Drug Deliv Rev 62(3):362–374
Feng X, Fryxell GE, Wang LQ, Kim AY, Lui J, Kemmer KM (1997) Science 276:923
Garcia-Bennett AE (2011) Synthesis, toxicology and potential of ordered mesoporous materials in nanomedicine. Nanomedicine (Lond) 6:867–877
Garcia-Bennett AE, Che S, Terasaki O, Tatsumi T (2004) Chem Mater 16:813
Garcia-Bennett AE, Kupferschmidt N, Sakamoto Y, Che S, Terasaki O (2005a) Angewandte Chemie Int Ed 117(3):5451–5456
Garcia-Bennett AE, Kupferschmidt N, Sakamoto Y, Che S, Terasaki O (2005b) Angew Chem Int Ed 44:2
Gratton SEA et al (2008) The effect of particle design on cellular internalization pathways. Proc Natl Acad Sci U S A 105(33):11613–11618
Han L, Ruan L, Li Y, Terasaki O, Che S (2007) Chem Mater 19(11):2860–2867
Higuchi T (1963) J Pharm Sci 52:1145
Hodgkins RP, Garcia-Bennett AE, Wright PA (2005) Micropor Mesopor Mat 79:241–252
Horcajada P, Rámila A, Pérez-Pariente J, Vallet-Regı M (2004) Micropor Mesopor Mat 68(1–3):105–109
Huang X et al (2011) ACS Nano 5(7):5390–5399
Hudson SP et al (2008) 29(30):4045–4055
Huo Q, Margolese DI, Ciesla U, Demuth DG, Feng P, Gier TE, Sieger P, Firouzi A, Chmelka BF, Schuth F, Stucky GD (1994) Chem Mater 6:1176–1191
Israelachvili JN (1991) Intermolecular and surface forces, 2nd edn. Academic press, New York
Jamzad S, Tutunji L, Fassihi R. (2005) Int J Pharm 292:75
Jiang Q, Ward MD (2014) Chem Soc Rev 43:2066–2079
Kerns EH, Di L (2003) Drug Discov Today 8:316–323
Kim JM, Kwak JH, Jun S, Ryoo RJ (1995) Phys Chem 99:16742–16747
Kleitz F, Liu D, Anilkumar GM, Park IS, Solovyov LA, Shmakov AN, Ryoo R (2003) J Phys Chem B 107:14296
Kolter (2011) Pharm Tech Eur 23(10):
Kosmidis K, Argyrakis P, Macheras P (2003) J Chem Phys 119:6373
Kresge CT, Leonowicz ME, Roth J, Vartuli JC, Beck JS (1992) Nature 359:710–712
Kumar ID, Chirravuri SVS, Shastri NR (2014) Int J Pharm 461:459–468
Kupferschmidt N, Xia X, Hanoi R, Atluri R, Ballel L, Garcia-Bennett AE (2013) Nanomedicine 8(1):57–64
Kupferschmidt N, Csikasz R, Ballel L, Bengtsson T, Garcia-Bennett AE (2014a) Nanomedicine. doi:10.2217/nnm.13.138
Kupferschmidt N, Qazi K, Kemi C, Vallhov H, Garcia-Bennett AE, Gabrielsson S, Scheynius A (2014b) Nanomedicine. doi:10.2217/nnm.13.170
Laaksonen T et al (2007) Chem Res Toxicol 20(12):1913–1918
Lin YS, Abadeer N, Haynes CL (2011) Stability of small mesoporous silica nanoparticles in biological media. Chem Commun 47(1):532–534
Liu T et al (2011) Biomaterials 32(6):1657–1668
Lu J, Liong M, Li Z, Zink JI, Tamanoi F (2010) Small 6(16):1794–1805
Lynch I, Salvati A, Dawson KA (2009) Protein-nanoparticle interactions: what does the cell see? Nat Nanotechnol 4(9):546–547
Marlow F, McGehee MD, Zhao D, Chmelka BF, Stucky GD (1999) Adv Mater 11:632
Mellaerts R, Mols R, Jammaer JA, Aerts CA, Annaert P, Humbeeck JV, Van den Mooter G, Augustijns P, Martens JA (2008) Eur J Pharm Biopharm 69:223–230
Mercuri LP et al (2006) Small 2(2):254–256
Prescribing information for atazanavir sulfate (Reyataz) capsules (2004) Bristol–Myers Squibb, Princeton
Raman NK, Anderson MT, Brinker CJ (1996) Chem Mater 8:1682–1701
Ravikovitch P, Neimark A (2002) Langmuir 18:1550
Ravikovitch PI, Wei D, Chueh WT, Haller GL, Neimark AV (1997) J Phys Chem B 101:3671
Recent progress in mesostructured materials. Proceedings of the 5th international mesostructured materials symposium (IMMS 2006) Shanghai, China, 5–7 August 2006. Edited by D. Zhao
Rhodes CJ (2010) Properties and applications of zeolites. Sci Prog 93:223–284
Ritger PL, Peppas NA (1987) J Control Release 5:23
Rosenholm J, Sahlgren C, Linden M (2010) Nanoscale 2:1870–188
Roy S, Quiñones R, Matzger AJ (2012) Cryst Growth Des 12(4):2122–2126
Ryoo R, Joo SH, Jun S (1999) J Phys Chem B 103:7743
Sakamoto K (2001) In: Xia J, Nnanna IA (eds) Surfactant science series vol 101. Protein-based surfactants Ch. 10 261–280 Dekker, New York
Sakamoto Y, Kaneda M, Terasaki O, Zhao DY, Kim JM, Stucky G, Shin HJ, Ryoo R (2000) Nature 408:449
Seddon JM, Templer RH (1995) In: Lipowsky R, Sackmann E (eds) Polymorphism of lipid-water systems. Handbook of Biological Physics, vol 1. Elsevier, New York
Serajuddin AT (1999) Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J Pharm Sci 88:1058–1066
Slowing I, Trewyn BG, Lin VSY (2006) J Am Chem Soc 128(46):14792–14793
Sosman RB (1965) The phases of silica. Rutgers University Press, New Brunswick
Sosnik A, Chiappetta DA, Carcaboso AM (2009) J Control Release 138:2–15
Strømme M, Brohede U, Atluri R, Garcia-Bennett AE (2009a) Nanomedicine Nanotechnology 1:140–148
Strømme M, Atluri R, Brohede U, Frenning G, Garcia-Bennett AE (2009b) Langmuir 25(8):4306–4310
Taguchi A, Schueth F (2004) Micropor Mesopor Mat 77:1–45
Takagi T et al (2006) Mol Pharm 3(6):631–643
Thomas JM (1994) Nature 368:289
Thomas JM, Thomas WJ (1997) Principles and practice of heterogeneous catalysis. VCH, Weinheim
Thomas JM, Raja R, Johnson BFG, O’Connell TJ, Sankar G, Khimyak T (2003) J Chem Soc Chem Commun 10:1126
Vallet-Regi M, Balas F, Arcos D (2007) Mesoporous materials for drug delivery. Angew Chem Int Edit 46(40):7548–7558
Vallet-Regi M, Ramila A, Real RP, Perez-Pariente (2001) J Chem Mater 13:308–312
Vallhov H, Gabrielsson S, Strömme M, Scheynius A, Garcia-Bennett AE (2007) Mesoporous silica particles induce size dependent effects on human dendritic cells. Nano Lett 7:3576–3582
Vallhov H, Kupferschmidt N, Gabrielsson S, Paulie S, Strømme M, Garcia-Bennett AE, Scheynius A (2012) Small 8 No 13:2116–2124
Van Speybroeck M et al (2010) Eur J Pharm Biopharm 21:623–630
Van Speybroeck M et al (2011) J PharmSci 100(11)
Vartuli JC, Kresge CT, Leonowicz ME, Chu AS, McCullen SB, Johnson ID, Sheppard EW (1994) Chem Mater 6:2070–2077
Vialpando M, Aerts A, Persoons J, Martens J, Van Den Mooter G (2011) J Pharm Sci 100(8):3411
Wan Y, Zhao DY (2007) Chem. Rev 107:2821–2860
Wang et al (2010a) J Control Release 145:257–263
Wang F, Barnes TJ, Prestidge CA (2010b) Mesoporous Biomaterials 1(1–16):2300–2271
Witasp E et al (2009) Toxicol Appl Pharmacol 239:306–319
Wong MS, Ying JY (1998) Chem Mater 10:2067
Wood AJJ (2006) N Engl J Med 355:618–623
Worle-Knirsch JM, Pulskamp K, Krug HF (2006) Nano Letters 6(6):1261–1268
Wu C, Chang J, (2012) Interface Focus 2(3):292–306
Xia X, Zhou C, Ballel L, Garcia-Bennett AE (2012a) Chem Med Chem 1:43–48
Xia X, Zhou C, Ballell L, Garcia-Bennett AE (2012b) Chem Med Chem 7:43–48
Yanagisawa T, Shimizu T, Kuroda K, Kato C (1990) Bull Chem Soc Jpn 63:988
Yongde X, Mokaya R (2003) J Phys Chem B 107(29):6954–6960
Zhao D et al (1998) Triblock copolymer syntheses of mesoporous silica with periodic 50–300 angstrom pores. Science 279:548–552
Zhao Y et al (2011) Interaction of mesoporous silica nanoparticles with humanred blood cell membranes: size and surface effects. ACS Nano 5(2):1366–1375
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Controlled Release Society
About this chapter
Cite this chapter
Garcia-Bennett, A., Feiler, A. (2014). Mesoporous ASD: Fundamentals. In: Shah, N., Sandhu, H., Choi, D., Chokshi, H., Malick, A. (eds) Amorphous Solid Dispersions. Advances in Delivery Science and Technology. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1598-9_22
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1598-9_22
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-1597-2
Online ISBN: 978-1-4939-1598-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)